within Pharmacolibrary.Drugs.ATC.D;

model D10AX30
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AX30</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Preparations under ATC code D10AX30 are topical dermatological agents containing various combinations primarily indicated for the treatment of acne vulgaris. These products typically combine multiple active ingredients, such as antibacterials, keratolytics, or retinoids, for synergistic therapeutic effects. This group is not a single, specific drug and composition may vary by product and manufacturer. Most combinations are not systemically absorbed in significant quantities and are approved for topical use only.</p><h4>Pharmacokinetics</h4><p>Estimated topical pharmacokinetic parameters for general healthy adults; no human systemic pharmacokinetic studies published as these preparations are minimally absorbed.</p><h4>References</h4><ol><li><p>Frangie, JP (1995). Clinical pharmacokinetics of various topical ophthalmic delivery systems. <i>Clinical pharmacokinetics</i> 29(2) 130–138. DOI:<a href=\"https://doi.org/10.2165/00003088-199529020-00006\">10.2165/00003088-199529020-00006</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7586901/\">https://pubmed.ncbi.nlm.nih.gov/7586901</a></p></li><li><p>Chernoff, G (2023). Combining topical dermal infused exosomes with injected calcium hydroxylapatite for enhanced tissue biostimulation. <i>Journal of cosmetic dermatology</i> 22 Suppl 1 15–27. DOI:<a href=\"https://doi.org/10.1111/jocd.15695\">10.1111/jocd.15695</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36988469/\">https://pubmed.ncbi.nlm.nih.gov/36988469</a></p></li><li><p>Fereig, SA, et al., &amp; Abdel-Mottaleb, MMA (2020). Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis. <i>Drug delivery</i> 27(1) 662–680. DOI:<a href=\"https://doi.org/10.1080/10717544.2020.1754527\">10.1080/10717544.2020.1754527</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32393082/\">https://pubmed.ncbi.nlm.nih.gov/32393082</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AX30;
